Upcoming Events

SIP related events

13th European Headache Congress

Since its foundation in 1992, EHF (European Headache Federation), a non-profit organization, has sought to improve the life of those affected by headache in Europe. To do so, EHF dedicates its efforts to improving awareness of headache disorders and their impact amongst governments, health care providers and consumers across Europe.

The 13th European Headache Federation Congress will be held in the Athens Concert Hall, “Megaron”, on May 30th - June 1st 2019.

Committed to the European Headache Federation mission of Science and Education through Renovation, this European Congress aims to improve the life of those affected by headache in Europe by giving light to the new scientific evidence on therapeutics, comorbidities and pathogenesis of headache. Amidst a plethora of new migraine treatments that have never reached this density, power and precision before, new alliances linking efforts guided by both sufferers and therapists lead to astonishing horizons. The Congress is focused on the detailed message identification and clarification of all novel treatments including those targeting the CGRP and 5- HT1F pathways, treatments targeting the PACAP signaling as well as neurostimulation trials. All the aspects of headache nosology will be covered with emphasis on the patient’s journey within this spectrum.

You can find additional information on the congress website.

Location: Athens, Greece

Since its foundation in 1992, EHF (European Headache Federation), a non-profit organization, has sought to improve the life of those affected by headache in Europe. To do so, EHF dedicates its efforts to improving awareness of headache disorders and their impact amongst governments, health care providers and consumers across Europe.
The 13th European Headache Federation Congress will be held in the Athens Concert Hall, “Megaron”, on May 30th - June 1st 2019.
Committed to the European Headache Federation mission of Science and Education through Renovation, this European Congress aims to improve the life of those affected by headache in Europe by giving light to the new scientific evidence on therapeutics, comorbidities and pathogenesis of headache. Amidst a plethora of new migraine treatments that have never reached this density, power and precision before, new alliances linking efforts guided by both sufferers and therapists lead to astonishing horizons. The Congress is focused on the detailed message identification and clarification of all novel treatments including those targeting the CGRP and 5- HT1F pathways, treatments targeting the PACAP signaling as well as neurostimulation trials. All the aspects of headache nosology will be covered with emphasis on the patient’s journey within this spectrum.
You can find additional information on the congress website.

Go back

  1. Societal Impact of Pain (SIP)
  2. Events
  3. Calendar
  4. Upcoming events
  • Register for the SIP Newsletter

    Stay informed about the most important events and news about the Societal Impact of Pain platform.

    subscribe now